# Effect of ANKASCIN 568-P Products Regulating Blood Lipid

> **NCT05737355** · NA · RECRUITING · sponsor: **SunWay Biotech Co., LTD.** · enrollment: 80 (estimated)

## Conditions studied

- Hyperlipidemias

## Interventions

- **DIETARY_SUPPLEMENT:** ANKASCIN 568-P Red yeast rice capsules
- **DIETARY_SUPPLEMENT:** Placebo Capsules

## Key facts

- **NCT ID:** NCT05737355
- **Lead sponsor:** SunWay Biotech Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737355, "Effect of ANKASCIN 568-P Products Regulating Blood Lipid". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05737355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*